Showing results (171-180 of 581) with videos related to
Sort By:
Pageof 59
Current Atherosclerosis Reports|December 29, 2022
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate ContinuesSamuel C R Sherratt, Peter Libby, Matthew J Budoff, et al.Circulation|October 13, 2010
High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosisKunio Morishige, Daniel F Kacher, Peter Libby, et al.Cardiovascular Research|January 22, 2024
Do patients benefit from omega-3 fatty acids?Samuel C R Sherratt, R Preston Mason, Peter Libby, et al.Circulation Research|April 6, 2002
PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosisNikolaus Marx, Bettina Kehrle, Klaus Kohlhammer, et al.Lancet (London, England)|November 18, 2017
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trialPaul M Ridker, Jean G MacFadyen, Brendan M Everett, et al.Journal of the American College of Cardiology|October 2, 2020
Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS TrialBrendan M Everett, Jean G MacFadyen, Tom Thuren, et al.European Journal of Clinical Investigation|July 24, 2024
Inflammation unites diverse acute and chronic diseasesPeter Libby, Robin Smith, Eric J Rubin, et al.Circulation|November 7, 2012
Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trialPaul M Ridker, Campbell P Howard, Verena Walter, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 5, 2004
Lysosomal cysteine proteases in atherosclerosisJian Liu, Galina K Sukhova, Jiu-Song Sun, et al.Atherosclerosis|April 28, 2009
Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL studyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.Pageof 59